Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
$1.80
$1.38
$3.66
$90.92M1.2656,165 shs10,300 shs
Forsys Metals Corp. stock logo
FSY
Forsys Metals
C$0.88
-4.3%
C$0.94
C$0.30
C$1.15
C$171.75M0.79308,668 shs41,717 shs
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$0.09
$0.11
$0.07
$1.28
$3.22M2.033.28 million shs1.15 million shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
0.00%0.00%0.00%0.00%+10.81%
Forsys Metals Corp. stock logo
FSY
Forsys Metals
-4.35%-5.38%-7.37%-5.38%+91.30%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
+0.34%-0.78%+3.00%-41.79%+8,929,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
N/AN/AN/AN/AN/AN/AN/AN/A
Forsys Metals Corp. stock logo
FSY
Forsys Metals
N/AN/AN/AN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
N/AN/AN/AN/A
Forsys Metals Corp. stock logo
FSY
Forsys Metals
N/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
$121.04M0.00N/A28.83$1.40 per share0.00
Forsys Metals Corp. stock logo
FSY
Forsys Metals
N/AN/AC$0.16 per share5.34C$0.11 per shareN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$14.73M0.22N/AN/A$0.12 per share0.74

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
-$580K-$0.01N/AN/AN/A-1.39%-5.84%-4.46%N/A
Forsys Metals Corp. stock logo
FSY
Forsys Metals
-C$5.82M-C$0.03N/AN/AN/A-24.57%-14.90%N/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
-$9.64M-$3.82N/A1.28N/A-65.46%-150.14%-53.48%5/28/2024 (Estimated)

Latest ATY, TSTR, FSY, and NBY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/26/2024Q4 2023
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A-$0.95-$0.95-$0.57N/A$3.73 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
N/AN/AN/AN/AN/A
Forsys Metals Corp. stock logo
FSY
Forsys Metals
N/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
0.04
3.69
3.69
Forsys Metals Corp. stock logo
FSY
Forsys Metals
N/A
6.34
279.14
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A
1.67
1.00

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
8.66%
Forsys Metals Corp. stock logo
FSY
Forsys Metals
29.96%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
23.25%

Insider Ownership

CompanyInsider Ownership
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
11.98%
Forsys Metals Corp. stock logo
FSY
Forsys Metals
37.11%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
0.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
18756.83 million50.02 millionNot Optionable
Forsys Metals Corp. stock logo
FSY
Forsys Metals
12195.17 millionN/ANot Optionable
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
2436.06 million36.03 millionNot Optionable

ATY, TSTR, FSY, and NBY Headlines

SourceHeadline
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial ResultsNovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
businesswire.com - May 9 at 4:05 PM
NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated by Analysts at StockNews.comNovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated by Analysts at StockNews.com
americanbankingnews.com - May 9 at 3:42 AM
NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through AmazonNovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
businesswire.com - May 7 at 8:00 AM
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
businesswire.com - May 3 at 6:50 AM
NovaBay Pharmaceuticals (NYSE:NBY) Earns Sell Rating from Analysts at StockNews.comNovaBay Pharmaceuticals (NYSE:NBY) Earns Sell Rating from Analysts at StockNews.com
americanbankingnews.com - May 1 at 2:14 AM
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova SalesNovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
businesswire.com - April 22 at 6:57 AM
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder EquityNovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
businesswire.com - April 19 at 6:00 PM
NovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call TranscriptNovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 28 at 9:16 PM
NovaBay Pharmaceuticals: Q4 Earnings InsightsNovaBay Pharmaceuticals: Q4 Earnings Insights
benzinga.com - March 26 at 10:00 PM
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial ResultsNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
finance.yahoo.com - March 26 at 10:00 PM
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
businesswire.com - March 25 at 6:38 PM
NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
businesswire.com - March 14 at 8:00 AM
NioBay Metals closes option agreement to acquire Foothills propertyNioBay Metals closes option agreement to acquire Foothills property
markets.businessinsider.com - February 21 at 8:30 AM
A Guide To The Risks Of Investing In Novabay Pharmaceuticals Inc (NBY)A Guide To The Risks Of Investing In Novabay Pharmaceuticals Inc (NBY)
knoxdaily.com - January 31 at 8:40 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

AcuityAds logo

AcuityAds

NYSE:ATY
AcuityAds Holdings, Inc. engages in the provision of digital advertising solutions. It operates through the following geographical segments: Unites States, Canada, and Europe and Other. The company was founded by Tal Hayek, Nathan Mekuz, Rachel Kapcan, and Joe Ontman on October 9, 2009 and is headquartered in Toronto, Canada.
Forsys Metals logo

Forsys Metals

TSE:FSY
Forsys Metals Corp. together with its subsidiaries, engages in the acquisition, exploration, and development of mineral properties in Africa. Its flagship project is the Norasa uranium project, which includes the Valencia and Namibplaas uranium projects located in the Republic of Namibia. The company was formerly known as Forsys Technologies Inc. and changed its name to Forsys Metals Corp. in June 2005. Forsys Metals Corp. was incorporated in 1985 and is headquartered in Toronto, Canada.
NovaBay Pharmaceuticals logo

NovaBay Pharmaceuticals

NYSE:NBY
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.